PREDiCT: Tumor Models San Francisco 2020

Jaeho Jung

Executive Vice President of R&D

ABL Bio

Amy Jo Casbon

Scientist in Immunotherapy & Oncology

Amgen Inc.

Deepali Sawant

Scientist, Oncology

Amgen Inc.

Shiva Kazerounian

Associate Director of In Vivo

Berg Health

Joshua Breunig

Assistant Proffesor

Cedars-Sinai Medical Center

Clive Svendsen

Lab Head

Cedars-Sinai Medical Center

Amy Wesa

Director of ImmunoOncology Research

Champions Oncology

Chung-Wein Lee

Senior Scientist

Celgene Corporation

Erin Riegler

Scientist

Chimera Bioengineeing

Angus Sinclair

Vice President

IGM Biosciences

Dean O Campbell

Director Scientific Engagement Oncology-West

Crown BioScience, Inc.

James Keck

Senior Director for the Clinical Lab & In Vivo Pharmacology Services

The Jackson Laboratory

Keiji Furuuchi

Director, Preclinical Development, Epochal Precision Anti Cancer Therapeutics (EPAT)

Eisai

Tseten Jamling

VP of Research and Development

Hera BioLabs, Inc.

Wei Sun

Professor

Drexel University

Gregor Adams

Director of Scientific Development

MI Bioresearch

Jim Hodge

Deputy Chief, Laboratory of Tumor Immunology and Biology Senior Investigator

National Institutes of Health

Saad Sirop Kenderian

Senior Associate Consultant - Hematology, Immunology & Molecular Medicine

Mayo Clinic

Kimberly Aardalen

Scientific Technical Leader

Novartis Institutes for Biomedical Research

Loui Madakamutil

Senior Vice President & Head of Discovery & Preclinical Development

Nektar Therapeutics

Matthias von Herrath

Vice President & Senior Medical Officer

Global Chief Medical Office Novo Nordisk

Daniel Harrington

Assistant Proffesor

University of Texas Health Science Center

Sarah Gitto

Project Lead

University of Pennsylvania

Pengfei Zhou

Chief Executive Officer

YZY Biopharma Co Ltd

Rosemary Akhurst